Загрузка...
Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study
BACKGROUND: Major depressive disorder (MDD) is a common psychiatric disorder. With systematic antidepressant treatment, 50–75% of patients have a treatment response but require 4–6 weeks to have their symptoms alleviated. Therefore, researchers anticipate the development of novel fast-acting antidep...
Сохранить в:
| Опубликовано в: : | Trials |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327443/ https://ncbi.nlm.nih.gov/pubmed/30626424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-3115-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|